Main author:

Joanne G. Wildenbeest (2 – UMCU)

Work Package:

WP3 - Clinical validation studies (Prospective studies)

PDF file

The PROMISE case-control validation study (study 2) is a prospective monocenter study conducted at UMC Utrecht. The main objective of this study is to validate biomarkers for severity of RSV disease in infants identified in the RESCEU infant studies. The study started in November 2021. Until now biological samples and clinical information have been collected from 102 previously healthy infants (<1 year of age) sub-divided into different groups specified in the deliverable.

Published On: November 8, 2023